Cargando…

Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia

BACKGROUND: Indonesia ranking third in the world, regarding leprosy burden. Chemoprophylaxis is effective in reducing risk of developing leprosy among contacts. ‘Blanket approach’ is an operational strategy for leprosy post-exposure prophylaxis in which all members of an isolated community, high end...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiwari, Anuj, Dandel, Steaven, Djupuri, Rita, Mieras, Liesbeth, Richardus, Jan Hendrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042242/
https://www.ncbi.nlm.nih.gov/pubmed/29996781
http://dx.doi.org/10.1186/s12879-018-3233-3
_version_ 1783339113961750528
author Tiwari, Anuj
Dandel, Steaven
Djupuri, Rita
Mieras, Liesbeth
Richardus, Jan Hendrik
author_facet Tiwari, Anuj
Dandel, Steaven
Djupuri, Rita
Mieras, Liesbeth
Richardus, Jan Hendrik
author_sort Tiwari, Anuj
collection PubMed
description BACKGROUND: Indonesia ranking third in the world, regarding leprosy burden. Chemoprophylaxis is effective in reducing risk of developing leprosy among contacts. ‘Blanket approach’ is an operational strategy for leprosy post-exposure prophylaxis in which all members of an isolated community, high endemic for leprosy are screened and given a single dose of rifampicin (SDR) in the absence of signs and symptoms of leprosy. The objective is to assess the operational feasibility of a population-wide ‘blanket’ administration of SDR for leprosy prevention in isolated communities in a remote island. METHODS: A prospective follow-up study was conducted in the year 2014, 2015 and 2016 in Lingat village of Selaru Island, Indonesia. During the first two visits, screening and SDR were provided, whereas only screening was conducted during the third visit. The demographic and clinical data were used for a descriptive analysis of the project coverage and leprosy epidemiology. RESULTS: During the first two visits, 1671 persons (88%) were screened, 1499 (79%) received SDR, and 213 (11%) were excluded based on the exclusion criteria. During the first two visits, 43 (2.6%) cases were diagnosed with leprosy with a rate of 2263 per 100,000 population. The prevalence was highest in the age groups 15–24 and 25–49 years. Total, 14 (33%) cases had MB and 29 (67%) PB leprosy. Two cases (5%) had grade 2 disability. During the third visit, 10 new leprosy cases, with no grade 2 disability, were detected out of 1481 screened persons at the rate of 484 cases per 100,000 population (n = 2065 population in 2016). Among those screened during the third visit, there was a 50% reduction of leprosy among those who had previously received SDR compared to those who had not. CONCLUSION: With adequate planning and some additional investment, it is feasible to implement a blanket approach of chemoprophylaxis in a remote island of Indonesia, although effort needs to be made to cover as many people as possible in the first visit. Contingency plans need to be made to actively follow this village closely in the coming years and continue leprosy elimination efforts until no new cases are found any more. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3233-3) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6042242
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-60422422018-07-13 Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia Tiwari, Anuj Dandel, Steaven Djupuri, Rita Mieras, Liesbeth Richardus, Jan Hendrik BMC Infect Dis Research Article BACKGROUND: Indonesia ranking third in the world, regarding leprosy burden. Chemoprophylaxis is effective in reducing risk of developing leprosy among contacts. ‘Blanket approach’ is an operational strategy for leprosy post-exposure prophylaxis in which all members of an isolated community, high endemic for leprosy are screened and given a single dose of rifampicin (SDR) in the absence of signs and symptoms of leprosy. The objective is to assess the operational feasibility of a population-wide ‘blanket’ administration of SDR for leprosy prevention in isolated communities in a remote island. METHODS: A prospective follow-up study was conducted in the year 2014, 2015 and 2016 in Lingat village of Selaru Island, Indonesia. During the first two visits, screening and SDR were provided, whereas only screening was conducted during the third visit. The demographic and clinical data were used for a descriptive analysis of the project coverage and leprosy epidemiology. RESULTS: During the first two visits, 1671 persons (88%) were screened, 1499 (79%) received SDR, and 213 (11%) were excluded based on the exclusion criteria. During the first two visits, 43 (2.6%) cases were diagnosed with leprosy with a rate of 2263 per 100,000 population. The prevalence was highest in the age groups 15–24 and 25–49 years. Total, 14 (33%) cases had MB and 29 (67%) PB leprosy. Two cases (5%) had grade 2 disability. During the third visit, 10 new leprosy cases, with no grade 2 disability, were detected out of 1481 screened persons at the rate of 484 cases per 100,000 population (n = 2065 population in 2016). Among those screened during the third visit, there was a 50% reduction of leprosy among those who had previously received SDR compared to those who had not. CONCLUSION: With adequate planning and some additional investment, it is feasible to implement a blanket approach of chemoprophylaxis in a remote island of Indonesia, although effort needs to be made to cover as many people as possible in the first visit. Contingency plans need to be made to actively follow this village closely in the coming years and continue leprosy elimination efforts until no new cases are found any more. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-018-3233-3) contains supplementary material, which is available to authorized users. BioMed Central 2018-07-11 /pmc/articles/PMC6042242/ /pubmed/29996781 http://dx.doi.org/10.1186/s12879-018-3233-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Tiwari, Anuj
Dandel, Steaven
Djupuri, Rita
Mieras, Liesbeth
Richardus, Jan Hendrik
Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia
title Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia
title_full Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia
title_fullStr Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia
title_full_unstemmed Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia
title_short Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia
title_sort population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in indonesia
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042242/
https://www.ncbi.nlm.nih.gov/pubmed/29996781
http://dx.doi.org/10.1186/s12879-018-3233-3
work_keys_str_mv AT tiwarianuj populationwideadministrationofsingledoserifampicinforleprosypreventioninisolatedcommunitiesathreeyearfollowupfeasibilitystudyinindonesia
AT dandelsteaven populationwideadministrationofsingledoserifampicinforleprosypreventioninisolatedcommunitiesathreeyearfollowupfeasibilitystudyinindonesia
AT djupuririta populationwideadministrationofsingledoserifampicinforleprosypreventioninisolatedcommunitiesathreeyearfollowupfeasibilitystudyinindonesia
AT mierasliesbeth populationwideadministrationofsingledoserifampicinforleprosypreventioninisolatedcommunitiesathreeyearfollowupfeasibilitystudyinindonesia
AT richardusjanhendrik populationwideadministrationofsingledoserifampicinforleprosypreventioninisolatedcommunitiesathreeyearfollowupfeasibilitystudyinindonesia